Email this article Impact of sarcopenic obesity on the clinical characteristics of older patients with visual impairment
- Authors: Kopylov A.E.1
-
Affiliations:
- S.N. Fedorov National Medical Research Center «MNTK Eye Microsurgery»
- Issue: Vol 28, No 2 (2025)
- Pages: 81-87
- Section: ORIGINAL STUDY ARTICLE
- URL: https://ogarev-online.ru/1560-9537/article/view/357915
- DOI: https://doi.org/10.17816/MSER680100
- EDN: https://elibrary.ru/MMREJY
- ID: 357915
Cite item
Open Access
Access granted
Subscription Access
Abstract
BACKGROUND: Sarcopenia and obesity, collectively referred to as sarcopenic obesity, are associated with decreased functional activity and mobility, as well as an increased risk of falls and fractures. However, the clinical characteristics and geriatric syndromes in older patients with visual impairment and sarcopenic obesity have not been previously studied.
AIM: The work aimed to investigate the impact of sarcopenic obesity on the clinical characteristics and geriatric syndromes of older patients with visual impairment.
METHODS: The study examined 203 older adults with sarcopenic obesity and visual impairment. Sarcopenic obesity was defined as the coexistence of sarcopenia and obesity in the same visually impaired patient, characterized by both increased body fat and loss of muscle mass. Obesity was assessed by a body mass index of ≥30.0 kg/m2, and sarcopenia was evaluated according to the European Working Group on Sarcopenia in Older People scale. Assessment tools included the Short Physical Performance Battery (SPPB), ADL, IADL, and CES-D scales. Nutritional status was evaluated using the Mini Nutritional Assessment (MNA).
RESULTS: The prevalence of sarcopenic obesity was 51.7%. Older adults with visual impairment who lived alone were more likely to have sarcopenic obesity compared to patients aged 60–74 years with visual impairment but without sarcopenic obesity (52.0 ± 1.2 vs 35.1 ± 1.5 percent). The incidence of cognitive impairment was also higher in older patients with both visual impairment and sarcopenic obesity. Sarcopenic obesity influenced the development of geriatric frailty syndrome, the frequency of falls, and reductions in basic and instrumental activities of daily living among patients aged 60–74 years with visual impairment. The body mass index of older patients with both visual impairment and sarcopenic obesity averaged 32.1 ± 1.1 kg/m2, confirming the presence of the condition.
CONCLUSION: Sarcopenic obesity affects the geriatric status of older patients with visual impairment. From a gerontoprophylactic standpoint, these patients require more careful and continuous monitoring by gerontologists, geriatricians, and ophthalmologists.
Full Text
##article.viewOnOriginalSite##About the authors
Andrey E. Kopylov
S.N. Fedorov National Medical Research Center «MNTK Eye Microsurgery»
Author for correspondence.
Email: kopylovx@mail.ru
ORCID iD: 0000-0002-3536-1645
SPIN-code: 3584-5021
MD, Cand. Sci. (Medicine)
Russian Federation, TambovReferences
- Scott D, Seibel M, Cumming R. Sarcopenic Obesity and Its Temporal Associations With Changes in Bone Mineral Density, Incident Falls, and Fractures in Older Men: The Concord Health and Ageing in Men Project. J Bone Miner Res. 2017;32(3):575–583. doi: 10.1002/jbmr.3016
- Follis S, Cook A, Bea JW. Association Between Sarcopenic Obesity and Falls in a Multiethnic Cohort of Postmenopausal Women. J Am Geriatr Soc. 2018;66(12):2314–2320. doi: 10.1111/jgs.15613
- Huo YR, Suriyaarachchi P, Gomez F. Phenotype of sarcopenic obesity in older individuals with a history of falling. Arch Gerontol Geriatr. 2016;65:255–259. doi: 10.1016/j.archger.2016.04.003
- Cauley JA. An Overview of Sarcopenic Obesity. J Clin Densitom. 2015;18(4):499–505. doi: 10.1016/j.jocd.2015.04.013
- Agarkov NM, Fabrikantov OL, Lev IV, et al. Features of the complement system in primary open-angle glaucoma and dry eye syndrome in the elderly. Medical Immunology. 2022;22(4):301–308. doi: 10.15789/1563-0625-FOT-2394 EDN: YARZNI
- Lev IV, Agarkov NM, Starodubtseva LV. Geriatric management of patients with diabetic retinopathy. Research Results in Biomedicine. 2023;9(1):129–141. doi: 10.18413/2658-6533-2023-9-1-0-9 EDN: ISHBBB
- Tornero-Quinones I, Saez-Padilla J, Diaz AE, et al. Functional Ability, Frailty and Risk of Falls in the Elderly: Relations with Autonomy in Daily Living. Int J Environ Res Public Health. 2020;17(3):1006–1015. doi: 10.3390/ijerph17031006
- Jones N, Bartlett HE. Comparison of the eating behaviour and dietary consumption in older adults with and without visual impairment. Br J Nutr. 2020;123(6):712–720. doi: 10.1017/S000711451900312X
- Swenor BK, Lee MJ, Tian J, et al. Visual impairment and frailty: Examining an understudied relationship. J Gerontol Ser A. 2020;75(3):596–602. doi: 10.1093/gerona/glz182
- Gbessemehlan A, Kehoua G, Helmer C, et al. Self-reported vision impairment and frailty among older people with low cognitive performance in Central Africa: EPIDEMCA population-based study. Dement Geriatr Cogn Disord. 2021;50(4):326–332. doi: 10.1159/000518601
- Wei S, Nguyen TT, Zhang Y, et al. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne). 2023;14:1185221. doi: 10.3389/fendo.2023.1185221
- Gorelik SG. Questionnaires and scales in gerontology and geriatrics. Gerontology. 2021;9(1):1–91.
- Liljas AE, Carvalho LA, Papachristou E, et al. Self-reported vision impairment and incident prefrailty and frailty in English community-dwelling older adults: Findings from a 4-year follow-up study. J Epidemiol. Community Health. 2017;71(11):1053–1058. doi: 10.1136/jech-2017-209207
Supplementary files
